Total Current Liabilities

$3.94B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$3.94Bperiod endingJun 30, 2026

VRTX Quarterly Current Liabilities ($1.60M → $3.94B)

Quarterly total current liabilities

High-resolution chart · PNG

VRTX total current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Total Current Liabilities — Quarterly (USD)
Period ending	Total Current Liabilities (USD)
Jun 30, 2001	38,852,000
Mar 31, 2001	31,872,000
Dec 31, 2000	69,856,000
Sep 30, 2000	199,837,000
Jun 30, 2000	24,591,000
Mar 31, 2000	16,039,000
Dec 31, 1999	18,518,000
Sep 30, 1999	13,100,000
Jun 30, 1999	14,200,000
Mar 31, 1999	13,800,000
Dec 31, 1998	13,100,000
Sep 30, 1998	11,200,000
Jun 30, 1998	8,700,000
Mar 31, 1998	8,700,000
Dec 31, 1997	13,700,000
Sep 30, 1997	11,800,000
Jun 30, 1997	9,300,000
Mar 31, 1997	9,100,000
Dec 31, 1996	7,100,000
Sep 30, 1996	5,400,000
Jun 30, 1996	7,500,000
Mar 31, 1996	7,500,000
Dec 31, 1995	8,800,000
Sep 30, 1995	7,800,000
Jun 30, 1995	8,700,000
Mar 31, 1995	5,900,000
Dec 31, 1994	6,000,000
Sep 30, 1994	7,400,000
Jun 30, 1994	6,900,000
Mar 31, 1994	5,600,000
Dec 31, 1993	7,300,000
Sep 30, 1993	6,200,000
Jun 30, 1993	4,600,000
Mar 31, 1993	4,700,000
Dec 31, 1992	3,900,000
Sep 30, 1992	3,200,000
Jun 30, 1992	2,900,000
Mar 31, 1992	2,600,000
Dec 31, 1991	2,700,000
Sep 30, 1991	2,300,000
Jun 30, 1991	2,200,000
Dec 31, 1990	1,600,000